1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Enteral and Parenteral Medical Nutrition Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Enteral and Parenteral Medical Nutrition Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Rising Number of Gastrointestinal Diseases in geriatric population is propelling the market growth
5.2 Market Opportunities
- 5.2.1 Increasing Cases of Malnutrition and Premature Births in emerging nations is augmenting the demand for enteral and parenteral nutrition products
5.3 Future Trends
- 5.3.1 Growing Strategic Initiatives by Key Companies
5.4 Impact of Drivers and Restraints
6. North America Enteral and Parenteral Medical Nutrition Market Regional Analysis
6.1 North America Enteral and Parenteral Medical Nutrition Market Overview
6.2 North America Enteral and Parenteral Medical Nutrition Market Revenue 2021-2028 (US$ Million)
6.3 North America Enteral and Parenteral Medical Nutrition Market Forecast Analysis
7. North America Enteral and Parenteral Medical Nutrition Market Analysis – by Indication
7.1 Elderly
- 7.1.1 Overview
- 7.1.2 Elderly: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Gastrointestinal Disorders
- 7.2.1 Overview
- 7.2.2 Gastrointestinal Disorders: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Diabetes
- 7.3.1 Overview
- 7.3.2 Diabetes: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Cancer
- 7.4.1 Overview
- 7.4.2 Cancer: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Respiratory Disorders
- 7.5.1 Overview
- 7.5.2 Respiratory Disorders: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Alzheimer's Disease
- 7.6.1 Overview
- 7.6.2 Alzheimer's Disease: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Dementia
- 7.7.1 Overview
- 7.7.2 Dementia: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Renal Disease
- 7.8.1 Overview
- 7.8.2 Renal Disease: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.9 Liver Failure
- 7.9.1 Overview
- 7.9.2 Liver Failure: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.10 Post COVID-19
- 7.10.1 Overview
- 7.10.2 Post COVID-19: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.11 Other Indications
- 7.11.1 Overview
- 7.11.2 Other Indications: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Enteral and Parenteral Medical Nutrition Market Analysis – by Nutrition Type
8.1 Supplemental
- 8.1.1 Overview
- 8.1.2 Supplemental: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Sole Source
- 8.2.1 Overview
- 8.2.2 Sole Source: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Enteral and Parenteral Medical Nutrition Market Analysis – by Form
9.1 Liquid
- 9.1.1 Overview
- 9.1.2 Sole Source: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Powder
- 9.2.1 Overview
- 9.2.2 Sole Source: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Semi Solid
- 9.3.1 Overview
- 9.3.2 Sole Source: North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Enteral and Parenteral Medical Nutrition Market – North America Analysis
10.1 North America
- 10.1.1 North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Key
Country, 2024 and 2028 (%)
- 10.1.1.1 North America Enteral and Parenteral Medical Nutrition Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 US: North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Indication
- 10.1.1.1.2 US: North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Nutrition Type
- 10.1.1.1.3 US: North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Form
- 10.1.1.2 Canada:
North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Canada: North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Indication
- 10.1.1.2.2 Canada: North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Nutrition Type
- 10.1.1.2.3 Canada: North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Form
- 10.1.1.3 Mexico :
North America Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 Mexico : North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Indication
- 10.1.1.3.2 Mexico : North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Nutrition Type
- 10.1.1.3.3 Mexico : North America Enteral and Parenteral Medical Nutrition Market Breakdown, by Form
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Enteral and Parenteral Medical Nutrition Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 B. Braun SE
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Baxter International Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Fresenius Kabi AG
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Medica Nutrition Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Medtrition Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Nestle SA
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Nutricia International BV
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Nutrisens SAS
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights